Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 4, 2002, Pages 401-409

  Creticos, Peter ^a   Knobil, Katharine ^b   Edwards, Lisa D ^b   Rickard, Kathleen A ^b   Dorinsky, Paul ^b  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; SALBUTAMOL; ZAFIRLUKAST;

ADULT; AGE DISTRIBUTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0036117943     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62372-1     Document Type: Article

References (39)

1. Underdiagnosis and undertreatment of asthma in the elderly
2. Asthma in the elderly: Underperceived, underdiagnosed and undertreated: A community survey
3. Predictors of asthma severity in the elderly: Results of a community survey in Northeast England
4. Is asthma in the elderly really different?
5. Lung disease in the elderly: Diagnosing asthma
6. Low dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
7. Fluticasone propionate versus zafirlukast: Effects in patients previously receiving inhaled corticosteroid therapy
8. Effect of switching patients with asthma from low dose inhaled corticosteroid therapy to low dose fluticasone or zafirlukast
9. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: A randomized, double-blind, placebo-controlled trial
10. A comparison of a short-term treatment with inhaled fluticasone propionate and zafirlukast in patients with persistent asthma
11. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
12. Effect of age on response to zafirlukast in patients with asthma in the Accolate clinical experience and pharmacoepidemiology trial (ACCEPT)
13. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial
14. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial
15. Treatment of asthma with drugs modifying the leukotriene pathway
16. Efficacy and safety of inhaled corticosteroids
17. 4 excretion
18. Increased levels of cysteinylleukotrienes in exhaled air condensate of aspirin-induced asthmatic patients
19. 4 and methacholine in normal subjects in vivo
20. Glucocorticosteroids inhibit leukotriene production
21. Inhibition of leukotriene (LT) production from eosinophils by fluticasone propionate (FP)
22. 4 secretion by fluticasone propionate in exogenously activated human eosinophils
23. Inhibition of human basophil leukotriene release by antiinflammatory steroids
24. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans
25. 4 in eosinophils obtained from asthmatic patients
26. 4 generation by human leukocytes in vitro
27. 4 and 11-dehydro-thromboxane B2 levels decrease by inhaled corticosteroid in asthmatic patients
28. 4 catabolism
29. Chronic inhaled glucocorticosteroid therapy reduces urinary leukotriene levels in asthmatics
30. Aging of the respiratory system
31. Lung function in the elderly
32. Changes in normal maximal expiratory flow-volume curve with growth and aging
33. Host factors affecting longitudinal decline in lung spirometry among grain elevator workers
34. Rate of decline of lung function in subjects with asthma
35. Asthma in the elderly: A comparison between patients with recently acquired and long-standing disease
36. Peripheral mononuclear leukocyte B adrenoceptors and non-specific bronchial responsiveness to methacholine in young and elderly normal subjects and asthmatic patients
37. Reduced β-adrenergic receptor concentration in aging man
38. 2-adrenergic receptor responsiveness in young and elderly asthmatics